An observational study in Nutritional Disorder, sponsored by Alexandria University. Completed. Open to participants aged 20 Years to 55 Years. Per ClinicalTrials.gov, last updated 2020-09-18.
Sponsored by Alexandria University · Observational
The aim of the study primarily was to investigate the value of zinc to copper ratio as possible biomarker of trace elements imbalance in morbidly obese subjects undergoing LSG.
Secondly to correlate zinc to copper ratio with lipocalin 2 (Lcn2) with respect to Anthropometric measurements and other metabolic biomarkers.
Prospective study will be carried out on 120 morbidly obese adult subjects with a body mass index (BMI) score above 40 along with presence of obesity-related comorbidity. Investigations will be measured preoperative and 9 months postoperative after performing Laparoscopic sleeve gastrectomy; for Body mass index (BMI) and waist circumference. As well as for complete blood count and biochemical biomarkers as fasting blood glucose, lipid profile, serum iron and ferritin. Serum Ceruloplasmin, Zn and Cu levels, followed by calculation of zinc to copper ratio. CRP, serum insulin, serum leptin and lipocalin-2 (Lcn2) will be determined.
CONSORT 2010 Flow Diagram
Materials and methods:
Recruitment Morbidly obese subjects attending clinic at Surgery department for laparoscopic sleeve gastrectomy Alexandria University Hospitals.
Pre-assignment Details adult morbidly obese subjects were included age above 20 years, BMI above 40 Suffering from comorbidities as hypertension, DM, dyslipidemia. Assigned participants were clinically evaluated for comorbidities as hypertension, DM, dyslipidemia.
As well as signs of nutritional deficiency as anemia, brittle nails.
Group Information one group of participants eligible for laparoscopic sleeve gastrectomy were assigned according to their will to participate in study.
Period of evaluation:
First visit: preoperative for clinical assessment of participants, determine BMI and waist circumference and withdrawal of serum blood sample Second visit: within one month after surgery to make sure that no complication occurred after surgery.
Third visit: nine months postoperative for revaluation of participants, determine BMI and waist circumference, and withdrawal of a serum blood sample
Number of participants at initiating the period of study. They were 120 morbidly obese subjects. Number of participants at the end of the period of study. They were 107 subjects, 13 obese subject withdraw from study as they didn't come during follow up period after 9 months.
Participants according Sex (69 females, and 38 male), with the mean age of 41.6±8.9 years. The mean preoperative BMI was 47.43±5.4 kg/m2. Then, they were evaluated 9 months after LSG.
Preoperative and Postoperative Clinical characteristics and metabolic variables in studied subjects.
Preoperative 9 months postoperative P Body weight (Kg) 129.7 ± 12.1 93.4 ±13.6 0.0013* BMI (kg/m2) 47.43±5.4 35.7±3.8 0.0052* Waist circumference (cm) 130.00 ± 4.68 91.82 ± 3.73 0.001* Systolic BP (mmHg) 146.0±17.0 132.0±11.0 0.001* Total cholesterol (mmol/L) 5.85 ± 0.41 4.64 ± 0.31 0.035* Triglycerides (mmol/L) 2.20 ± 0.23 1.92 ± 0.24 0.106 HDL cholesterol (mmol/L) 1.23 ± 0.19 1.39 ± 0.2 0.041* LDL cholesterol (mmol/L) 3.37 ± 0.23 2.97 ± 0.21 0.022* HOMA-IR 2.64 ± 1.3 1.44 ± 0.81 0.013* S. Leptin (ng/ml) 102.87 ± 49.16 33.47 ±12.76 0.0001* CRP (mg/L) 8.4±5.91 3.2±2.98 0.001* Lipocalin 2 (µg/L) 107.24±36.8 51.6±12.73 0.001* Albumin (g/dl) 4.05±0.21 3.91±0.29 0.113
*Statistically significant at (p≤0.05).
Outcome measures:
primarily was to investigate the value of zinc to copper ratio as possible biomarker of TE imbalance in morbidly obese subjects undergoing LSG.
For detection of presence of micronutrient deficiency in morbid obesity in form of zinc to copper ratio and re-evaluate it after loss of weight
Secondly to correlate it with lipocalin 2 (Lcn2) with respect to Anthropometric measurements and other metabolic markers prospectively.
As zinc to copper ratio is considered as biomarker of micronutrient status; therefore, correlate it with other biomarkers of inflammation (lipocalin 2) and other parameters as BMI, FBG to determine if micronutrient status improve after weight loss or not Time frame: 9 months.
Follow-up and outcome parameters:
All studied subjects will be followed up for early postoperative complications (within the first month) as Bleeding or Leak. Then they will be reviewed after 9 months postoperatively for assessment of anthropometric measurements, control of preoperative comorbidities, and manifestations of TE deficiencies (anemia, hair loss, teeth problems, edema. etc.).
Anthropometric parameters
Body mass index (BMI) and waist circumference will be measured preoperative and 9 months postoperative.
Biochemical parameters
Fasting blood samples will be collected from participants prior to surgery and nine months postoperative, after overnight fast and divided into two tubes; EDTA for complete blood count, the rest into plastic tubes and serum sample.
Serum glucose and Total cholesterol, HDL- cholesterol, LDL- cholesterol, and triglyceride, total protein and Albumin. Serum iron (Fe), and ferritin.
Serum insulin, Ceruloplasmin, Zn and Cu levels, CRP and lipocalin-2 (Lcn2) .
Statistical analysis
All data will be analyzed with Statistical Package for the Social Sciences version 20 software (SPSS, Inc., Chicago, IL). Results will be displayed as mean ± SD. Paired Student's t-test used to compare the data pre-operative and nine months postoperative. The chi-squared test used for category variables. Spearman correlation coefficient used to detect the correlation between different variables. Statistical correlations calculated by Pearson's correlation test. P \< 0.05 is considered significant.
275 studies on the registry are indexed under Nutrition Disorders; 31 are open to participants now.
This study's enrollment of 107 is close to the median of 108 across 74 observational studies indexed under Nutrition Disorders.
Browse Nutrition Disorders studies →Alexandria University is the lead sponsor of 569 studies on the registry; 125 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
adult obese subjects with BMI above 40 both males and females presence of obesity comorbidities as hypertension, insulin resistance "type 2 DM" eligible for laporoscopic sleeve gatrectomy
Exclusion Criteria:
BMI and biochemical parameters including trace elements in patients undergoing laparoscopic sleeve gastrectomy before surgery
Procedure: laparoscopic sleeve gastrectomy
BMI and biochemical parameters including trace elements in patients 9 months after laparoscopic sleeve gastrectomy
Procedure: laparoscopic sleeve gastrectomy
bariatric surgery to loss weight
Evaluation of zinc to copper ratio as biomarker of micro-nutrient deficiency
detect if there are micronutrient deficiency in morbid obesity in form of zinc to copper ratio and re-evaluate it after loss of weight
Time frame: nine months
correlate zinc to copper ratio to lipocalin 2 and other metabolic biomarkers
zinc to copper ratio is considered as biomarker of micronutrient status; therefore, it is correlated it with BMI, other biomarkers of inflammation (lipocalin 2) and other parameters as BMI, FBG to determine if micronutrient status improve after weight loss or not
Time frame: nine months
No study locations are listed for this record.
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is completed, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Alexandria University